The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2016

Filed:

May. 12, 2008
Applicants:

Carl Arne Krister Borrebaeck, Lund, SE;

Sara Ek, Lund, SE;

Inventors:

Carl Arne Krister Borrebaeck, Lund, SE;

Sara Ek, Lund, SE;

Assignee:

Immunovia AB, Lund, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); G01N 33/574 (2006.01); C07K 16/00 (2006.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 51/1069 (2013.01); C07K 16/00 (2013.01); G01N 33/57496 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2500/20 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides a binding moiety which selectively binds to Sox11 protein and/or mRNA for imaging, diagnosis or prognosis of lymphomas, such as mantle cell lymphomas (MCL) and diffuse large B-cell lymphoma (DLBCL). Optionally, the moiety is an antibody or antigen-binding fragment thereof. Advantageously, moiety comprises a further, readily detectable moiety. The invention also provides methods of imaging lymphomas cells as well as methods of diagnosing or prognosing lymphomas in an individual. A further aspect of the present invention provides a method of identifying cells associated with lymphomas, the method comprising analyzing the pattern of gene expression in a sample of cells to be tested and comparing it to the pattern of gene expression in a sample of known lymphomas cells. Preferably, the cells to be tested are identified as lymphoma cells if the expression of Sox11 is upregulated compared to normal B-cells.


Find Patent Forward Citations

Loading…